MaxQ-AI Receives CE Mark Approval for Accipio(TM)Ix Intracranial Hemorrhage Artificial Intelligence Software Platform
TEL AVIV, Israel, May 22, 2018 -- (Healthcare Sales & Marketing Network) -- MaxQ Artificial Intelligence (MaxQ-AI), a global artificial intelligence (AI) healthcare company, today announced that it has received the CE Mark approval for its revolutionary A... Devices, Radiology, Neurology, Regulatory MaxQ-AI, Accipio, intracranial hemorrhage, CT
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Israel Health | Marketing | Middle East Health | Neurology | Pharmaceuticals | Radiology